A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival

Alireza A. Shamshirsaz, Thomas Buekers, Koenraad De Geest, David Bender, Gideon Zamba, Michael J. Goodheart

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The aim of this study was to identify prognostic factors and markers that influence clinical outcomes in patients with primary fallopian tube carcinoma at a single tertiary health care center. These prognostic factors may be of clinical importance and can subsequently be included in future clinical trials. Materials and Methods: A retrospective review of our Tumor Registry and Gynecologic Oncology database was conducted to include any patients with a diagnosis of fallopian tube carcinoma between the years 1994 and 2005. We identified clinicopathological data to evaluate factors important in recurrence, disease-specific and overall survival. Kaplan-Meier curves were generated, and log-rank tests were used to evaluate survival differences. Results: Thirty-six patients had a diagnosis with primary fallopian tube carcinoma at a median age of 69 years. Patients most frequently presented with abdominal pain (19%) and a palpable mass (14%). The most common histological subtype was papillary serous adenocarcinoma in 56% of cases. Stage III disease (39%) and poorly differentiated tumors (81%) were most common. The median follow-up was 39.6 months. The 5-year cancer-specific survival was 42%, and the overall survival rate was 34%. Factors important in disease-free survival were International Federation of Gynecology and Obstetrics stage, tumor laterality, and serum CA-125, whereas International Federation of Gynecology and Obstetrics stage, serum CA-125, and residual disease were prognostic factors for overall survival. The most common locations of recurrence were pelvis and abdomen (63%) as opposed to distant sites. Factors associated with recurrence were stage, tumor laterality, and serum CA-125. Conclusions: Fallopian tube malignancies are rare. We have identified factors associated with recurrence, disease specific survival, and overall survival that could be further examined and included in larger clinical trials involving this uncommon malignancy.

Original languageEnglish (US)
Pages (from-to)1232-1240
Number of pages9
JournalInternational Journal of Gynecological Cancer
Volume21
Issue number7
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Fallopian Tubes
Carcinoma
Recurrence
Survival
Neoplasms
Gynecology
Obstetrics
Serum
Clinical Trials
Papillary Adenocarcinoma
Pelvis
Tertiary Care Centers
Abdomen
Abdominal Pain
Disease-Free Survival
Registries
Survival Rate
Biomarkers
Databases
Delivery of Health Care

Keywords

  • Fallopian tube carcinoma
  • Laterality
  • Prognostic factors
  • Survival

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Medicine(all)

Cite this

A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival. / Shamshirsaz, Alireza A.; Buekers, Thomas; De Geest, Koenraad; Bender, David; Zamba, Gideon; Goodheart, Michael J.

In: International Journal of Gynecological Cancer, Vol. 21, No. 7, 10.2011, p. 1232-1240.

Research output: Contribution to journalArticle

Shamshirsaz, Alireza A. ; Buekers, Thomas ; De Geest, Koenraad ; Bender, David ; Zamba, Gideon ; Goodheart, Michael J. / A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival. In: International Journal of Gynecological Cancer. 2011 ; Vol. 21, No. 7. pp. 1232-1240.
@article{8e30999159804ae097a8da62af636d49,
title = "A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival",
abstract = "Objective: The aim of this study was to identify prognostic factors and markers that influence clinical outcomes in patients with primary fallopian tube carcinoma at a single tertiary health care center. These prognostic factors may be of clinical importance and can subsequently be included in future clinical trials. Materials and Methods: A retrospective review of our Tumor Registry and Gynecologic Oncology database was conducted to include any patients with a diagnosis of fallopian tube carcinoma between the years 1994 and 2005. We identified clinicopathological data to evaluate factors important in recurrence, disease-specific and overall survival. Kaplan-Meier curves were generated, and log-rank tests were used to evaluate survival differences. Results: Thirty-six patients had a diagnosis with primary fallopian tube carcinoma at a median age of 69 years. Patients most frequently presented with abdominal pain (19{\%}) and a palpable mass (14{\%}). The most common histological subtype was papillary serous adenocarcinoma in 56{\%} of cases. Stage III disease (39{\%}) and poorly differentiated tumors (81{\%}) were most common. The median follow-up was 39.6 months. The 5-year cancer-specific survival was 42{\%}, and the overall survival rate was 34{\%}. Factors important in disease-free survival were International Federation of Gynecology and Obstetrics stage, tumor laterality, and serum CA-125, whereas International Federation of Gynecology and Obstetrics stage, serum CA-125, and residual disease were prognostic factors for overall survival. The most common locations of recurrence were pelvis and abdomen (63{\%}) as opposed to distant sites. Factors associated with recurrence were stage, tumor laterality, and serum CA-125. Conclusions: Fallopian tube malignancies are rare. We have identified factors associated with recurrence, disease specific survival, and overall survival that could be further examined and included in larger clinical trials involving this uncommon malignancy.",
keywords = "Fallopian tube carcinoma, Laterality, Prognostic factors, Survival",
author = "Shamshirsaz, {Alireza A.} and Thomas Buekers and {De Geest}, Koenraad and David Bender and Gideon Zamba and Goodheart, {Michael J.}",
year = "2011",
month = "10",
doi = "10.1097/IGC.0b013e318220fc46",
language = "English (US)",
volume = "21",
pages = "1232--1240",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival

AU - Shamshirsaz, Alireza A.

AU - Buekers, Thomas

AU - De Geest, Koenraad

AU - Bender, David

AU - Zamba, Gideon

AU - Goodheart, Michael J.

PY - 2011/10

Y1 - 2011/10

N2 - Objective: The aim of this study was to identify prognostic factors and markers that influence clinical outcomes in patients with primary fallopian tube carcinoma at a single tertiary health care center. These prognostic factors may be of clinical importance and can subsequently be included in future clinical trials. Materials and Methods: A retrospective review of our Tumor Registry and Gynecologic Oncology database was conducted to include any patients with a diagnosis of fallopian tube carcinoma between the years 1994 and 2005. We identified clinicopathological data to evaluate factors important in recurrence, disease-specific and overall survival. Kaplan-Meier curves were generated, and log-rank tests were used to evaluate survival differences. Results: Thirty-six patients had a diagnosis with primary fallopian tube carcinoma at a median age of 69 years. Patients most frequently presented with abdominal pain (19%) and a palpable mass (14%). The most common histological subtype was papillary serous adenocarcinoma in 56% of cases. Stage III disease (39%) and poorly differentiated tumors (81%) were most common. The median follow-up was 39.6 months. The 5-year cancer-specific survival was 42%, and the overall survival rate was 34%. Factors important in disease-free survival were International Federation of Gynecology and Obstetrics stage, tumor laterality, and serum CA-125, whereas International Federation of Gynecology and Obstetrics stage, serum CA-125, and residual disease were prognostic factors for overall survival. The most common locations of recurrence were pelvis and abdomen (63%) as opposed to distant sites. Factors associated with recurrence were stage, tumor laterality, and serum CA-125. Conclusions: Fallopian tube malignancies are rare. We have identified factors associated with recurrence, disease specific survival, and overall survival that could be further examined and included in larger clinical trials involving this uncommon malignancy.

AB - Objective: The aim of this study was to identify prognostic factors and markers that influence clinical outcomes in patients with primary fallopian tube carcinoma at a single tertiary health care center. These prognostic factors may be of clinical importance and can subsequently be included in future clinical trials. Materials and Methods: A retrospective review of our Tumor Registry and Gynecologic Oncology database was conducted to include any patients with a diagnosis of fallopian tube carcinoma between the years 1994 and 2005. We identified clinicopathological data to evaluate factors important in recurrence, disease-specific and overall survival. Kaplan-Meier curves were generated, and log-rank tests were used to evaluate survival differences. Results: Thirty-six patients had a diagnosis with primary fallopian tube carcinoma at a median age of 69 years. Patients most frequently presented with abdominal pain (19%) and a palpable mass (14%). The most common histological subtype was papillary serous adenocarcinoma in 56% of cases. Stage III disease (39%) and poorly differentiated tumors (81%) were most common. The median follow-up was 39.6 months. The 5-year cancer-specific survival was 42%, and the overall survival rate was 34%. Factors important in disease-free survival were International Federation of Gynecology and Obstetrics stage, tumor laterality, and serum CA-125, whereas International Federation of Gynecology and Obstetrics stage, serum CA-125, and residual disease were prognostic factors for overall survival. The most common locations of recurrence were pelvis and abdomen (63%) as opposed to distant sites. Factors associated with recurrence were stage, tumor laterality, and serum CA-125. Conclusions: Fallopian tube malignancies are rare. We have identified factors associated with recurrence, disease specific survival, and overall survival that could be further examined and included in larger clinical trials involving this uncommon malignancy.

KW - Fallopian tube carcinoma

KW - Laterality

KW - Prognostic factors

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84856072124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856072124&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e318220fc46

DO - 10.1097/IGC.0b013e318220fc46

M3 - Article

C2 - 21720254

AN - SCOPUS:84856072124

VL - 21

SP - 1232

EP - 1240

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 7

ER -